Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Online Yoga Intervention in MPN Patients Evaluated

Haematologica; ePub 2017 Jun 8; Huberty, et al

Publish date:: June 25, 2017

A home-based, online yoga intervention is feasible in patients with myeloproliferative neoplasms (MPNs), and may improve symptom burden, according to a study involving 38 individuals.

Participants were asked to perform 60-minutes of yoga each week. They completed online surveys at baseline, as well as 7, 12, and 16 weeks later. Investigators assessed pain intensity, anxiety, depression, sleep disturbance, and sexual function. Among the results:

68% of responding participants felt either satisfied or very satisfied with online yoga.
Three-fourths felt that it was helpful for coping with MPN-related symptoms.
43% said that they were likely to continue online yoga.
82% said they would recommend online yoga to other MPN patients.
Participants experienced significant improvements in total symptom burden, anxiety, depression, sleep disturbance, and fatigue.
Outcomes were similar in those who completed more or less than the recommended 60 minutes per week.

Citation:

Huberty J, Eckert R, Gowin K, et al. Feasibility study of online-streamed yoga for symptom management in patients with myeloproliferative neoplasms. [Published online ahead of print June 8, 2017]. Haematologica. doi:10.3324/haematol.2017.168583.

This Week's Must Reads

Consider potential cognitive complications prior to androgen deprivation therapy,

Diabetes raises risk of prostate cancer mortality in obese men,

Salivation inhibition fails to reduce radioiodine toxicity in prostate cancer,

Highest positive surgical margin predicts poor survival after prostatectomy,

Young minority men are underinformed about prostate cancer screening,

Must Reads in Hematologic Malignancies

Long-term ibrutinib data in older patients, Barr PM et al. Haematologica. 2018;103(9):1502-10

Prognostic Score System for Patients with PMF, J Clin Oncol; ePub 2017 Dec 9; Gugliemelli, et al

These Patients Are More Apt to Be Depressed, Ann Hematol; ePub 2017 Dec 7; Shreders, et al

Survival Length Shortest in These Patients with MF, Eur J Haematol; ePub 2017 Dec 11; Masarova, et al

The Value of Ruxolitinib Before and After AlloSCT, Blood; ePub 2017 Dec 7; Poulose, Malysz, et al